[go: up one dir, main page]

FR2862540B1 - Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile - Google Patents

Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile

Info

Publication number
FR2862540B1
FR2862540B1 FR0313660A FR0313660A FR2862540B1 FR 2862540 B1 FR2862540 B1 FR 2862540B1 FR 0313660 A FR0313660 A FR 0313660A FR 0313660 A FR0313660 A FR 0313660A FR 2862540 B1 FR2862540 B1 FR 2862540B1
Authority
FR
France
Prior art keywords
volatile
pharmaceutical active
spray composition
polar phase
volatile silicone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0313660A
Other languages
English (en)
Other versions
FR2862540A1 (fr
Inventor
Franck Pitre
Laurent Fredon
Claire Mallard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0313660A priority Critical patent/FR2862540B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to MXPA06005587A priority patent/MXPA06005587A/es
Priority to EP08100323A priority patent/EP1952808A3/fr
Priority to PCT/EP2004/014085 priority patent/WO2005053666A1/fr
Priority to ES04803732T priority patent/ES2302060T3/es
Priority to AT04803732T priority patent/ATE388697T1/de
Priority to BRPI0416311-7A priority patent/BRPI0416311A/pt
Priority to CA002543577A priority patent/CA2543577A1/fr
Priority to JP2006540412A priority patent/JP2007511578A/ja
Priority to DE602004012440T priority patent/DE602004012440T2/de
Priority to AU2004294728A priority patent/AU2004294728A1/en
Priority to KR1020067009652A priority patent/KR20060105001A/ko
Priority to DK04803732T priority patent/DK1686972T3/da
Priority to PL04803732T priority patent/PL1686972T3/pl
Priority to RU2006121973/15A priority patent/RU2006121973A/ru
Priority to EP04803732A priority patent/EP1686972B1/fr
Priority to SI200430634T priority patent/SI1686972T1/sl
Priority to PT04803732T priority patent/PT1686972E/pt
Priority to CNA2004800344899A priority patent/CN1960718A/zh
Priority to ARP040104271A priority patent/AR046642A1/es
Publication of FR2862540A1 publication Critical patent/FR2862540A1/fr
Priority to US11/432,410 priority patent/US20070041910A1/en
Priority to ZA200605050A priority patent/ZA200605050B/en
Application granted granted Critical
Publication of FR2862540B1 publication Critical patent/FR2862540B1/fr
Priority to CY20081100500T priority patent/CY1107942T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0313660A 2003-11-21 2003-11-21 Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile Expired - Fee Related FR2862540B1 (fr)

Priority Applications (23)

Application Number Priority Date Filing Date Title
FR0313660A FR2862540B1 (fr) 2003-11-21 2003-11-21 Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
PL04803732T PL1686972T3 (pl) 2003-11-21 2004-11-17 Kompozycja możliwa do rozpylania dla podawania pochodnych witaminy D
PCT/EP2004/014085 WO2005053666A1 (fr) 2003-11-21 2004-11-17 Composition pulverisable destinee a administrer des derives de la vitamine d
ES04803732T ES2302060T3 (es) 2003-11-21 2004-11-17 Composicion pulverizable destinada a administrar derivados de la vitamina d.
AT04803732T ATE388697T1 (de) 2003-11-21 2004-11-17 Sprühbare zusammensetzung zur verabreichung von vitamin d derivaten
BRPI0416311-7A BRPI0416311A (pt) 2003-11-21 2004-11-17 composição, uso de uma composição e processo para melhorar a penetração de um agente ativo farmacêutico
CA002543577A CA2543577A1 (fr) 2003-11-21 2004-11-17 Composition pulverisable destinee a administrer des derives de la vitamine d
JP2006540412A JP2007511578A (ja) 2003-11-21 2004-11-17 ビタミンｄの投与のためのスプレー可能な組成物
DE602004012440T DE602004012440T2 (de) 2003-11-21 2004-11-17 Sprühbare zusammensetzung zur verabreichung von vitamin d derivaten
EP08100323A EP1952808A3 (fr) 2003-11-21 2004-11-17 Composition sous forme de spray comprenant du calcitriol
KR1020067009652A KR20060105001A (ko) 2003-11-21 2004-11-17 비타민 ｄ 유도체 투여용 분무성 조성물
EP04803732A EP1686972B1 (fr) 2003-11-21 2004-11-17 Composition pulverisable destinee a administrer des derives de la vitamine d
MXPA06005587A MXPA06005587A (es) 2003-11-21 2004-11-17 Composicion rociable para administracion de derivados de vitamina d.
RU2006121973/15A RU2006121973A (ru) 2003-11-21 2004-11-17 Распыляемая композиция для введения производных витамина d
DK04803732T DK1686972T3 (da) 2003-11-21 2004-11-17 Spröjtbart præparat til indgivelse af D-vitaminderivater
SI200430634T SI1686972T1 (sl) 2003-11-21 2004-11-17 Pršljiva zmes za administracijo derivatov D vitamina
PT04803732T PT1686972E (pt) 2003-11-21 2004-11-17 Composição pulverizável para a administração de derivados da itamina d
CNA2004800344899A CN1960718A (zh) 2003-11-21 2004-11-17 用于维生素d衍生物给药的可喷雾组合物
AU2004294728A AU2004294728A1 (en) 2003-11-21 2004-11-17 Sprayable composition for the administration of vitamin D derivatives
ARP040104271A AR046642A1 (es) 2003-11-21 2004-11-19 Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
US11/432,410 US20070041910A1 (en) 2003-11-21 2006-05-12 Pharmaceutical spray compositions comprising a bioactive agent, at least one volatile silicone and a non-volatile oily phase
ZA200605050A ZA200605050B (en) 2003-11-21 2006-06-20 Sprayable composition for the administration of vitamin D derivatives
CY20081100500T CY1107942T1 (el) 2003-11-21 2008-05-13 Ψεκασιμη συνθεση για τη χορηγηση παραγωγων της βιταμινης d

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0313660A FR2862540B1 (fr) 2003-11-21 2003-11-21 Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile

Publications (2)

Publication Number Publication Date
FR2862540A1 FR2862540A1 (fr) 2005-05-27
FR2862540B1 true FR2862540B1 (fr) 2007-03-30

Family

ID=34531173

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0313660A Expired - Fee Related FR2862540B1 (fr) 2003-11-21 2003-11-21 Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile

Country Status (6)

Country Link
US (1) US20070041910A1 (fr)
KR (1) KR20060105001A (fr)
CN (1) CN1960718A (fr)
AR (1) AR046642A1 (fr)
FR (1) FR2862540B1 (fr)
ZA (1) ZA200605050B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
US8211449B2 (en) * 2004-06-24 2012-07-03 Dpt Laboratories, Ltd. Pharmaceutically elegant, topical anhydrous aerosol foam
ES2447301T3 (es) * 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
FR2893847B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
EP1970048A1 (fr) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Composition topique de type polyaphron avec de la vitamine D
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (fr) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Patch bioérodable
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
KR101880032B1 (ko) 2009-08-14 2018-07-20 베르그 엘엘씨 탈모증 치료용 비타민 ｄ3 및 이의 유사체들
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
US9610245B2 (en) 2011-03-14 2017-04-04 Drug Delivery Solutions Limited Ophthalmic composition
CA2834301A1 (fr) * 2011-05-02 2012-11-08 Lipidor Ab Traitement du psoriasis
CA2913543C (fr) * 2013-05-29 2024-01-09 Berg Llc Prevention ou attenuation de l'alopecie induite par la chimiotherapie au moyen de vitamine d
CA2924748C (fr) 2013-10-03 2019-09-03 Dow Pharmaceutical Sciences, Inc. Formules d'efinaconazole stabilise
AU2014349256B2 (en) * 2013-11-14 2020-04-30 Lipidor Ab Sprayable topical carrier and composition comprising phosphatidylcholine
CA2931144C (fr) 2013-11-22 2020-02-04 Dow Pharmaceutical Sciences, Inc. Procedes, compositions et dispositifs anti-infectieux
CN119139479A (zh) 2015-09-16 2024-12-17 Dfb索里亚有限责任公司 包含紫杉烷类纳米颗粒的组合物及其用途
CN105193723A (zh) * 2015-10-23 2015-12-30 郑州泰丰制药有限公司 度骨化醇喷雾制剂及其制备方法
CN108430439B (zh) 2015-12-18 2021-03-02 帝斯曼知识产权资产管理有限公司 联芳香族维生素d类似物
WO2017102790A1 (fr) * 2015-12-18 2017-06-22 Dsm Ip Assets B.V. Analogues de la vitamine d constitués de composés biaromatiques
EP3389607B1 (fr) 2015-12-18 2020-07-15 DSM IP Assets B.V. Analogues biaromatiques de vitamine d
WO2017102791A1 (fr) * 2015-12-18 2017-06-22 Dsm Ip Assets B.V. Nouveaux composés
CA3056395C (fr) 2017-03-15 2022-06-28 Dfb Soria, Llc Therapie topique pour le traitement de malignites cutanees au moyen de nanoparticules de taxanes
US11497726B2 (en) 2018-03-16 2022-11-15 Dfb Soria, Ll. Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes
EP3542788A1 (fr) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Composition topique comprenant calcipotriol et dipropionate de bétaméthasone

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
FI872553L (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Medium foer laekemedel foer lokalt bruk.
US4889845A (en) * 1986-06-09 1989-12-26 American Cyanamid Company Vehicle for topical application of pharmaceuticals
JPH02145512A (ja) * 1988-11-26 1990-06-05 Shin Etsu Chem Co Ltd 被膜形成型外用剤
GB9109733D0 (en) * 1991-05-07 1991-06-26 Unilever Plc Cosmetic composition
JPH07118596A (ja) * 1993-10-25 1995-05-09 Daikin Ind Ltd 撥水撥油剤組成物およびその製法
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
US6231844B1 (en) * 1995-04-13 2001-05-15 The Procter & Gamble Company Nonionic surfactant foaming agents for foaming cosmetic compositions
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
EP0966972B1 (fr) * 1998-06-18 2003-09-24 Dow Corning France S.A. Composition topique contenant de la gomme de silicone
US20010002396A1 (en) * 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
US6410038B1 (en) * 2000-06-14 2002-06-25 Dow Corning Corporation Water-in-oil-in-polar solvent emulsions
US7655717B2 (en) * 2002-07-17 2010-02-02 Mary J. Goulbourne Ointment composition for treating decubitus ulcers and methods for its making and its use

Also Published As

Publication number Publication date
ZA200605050B (en) 2007-11-28
AR046642A1 (es) 2005-12-14
KR20060105001A (ko) 2006-10-09
FR2862540A1 (fr) 2005-05-27
US20070041910A1 (en) 2007-02-22
CN1960718A (zh) 2007-05-09

Similar Documents

Publication Publication Date Title
FR2856301B1 (fr) Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
FR2862540B1 (fr) Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
FR2871697B1 (fr) Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
DK1196163T3 (da) Farmaceutiske sammensætninger til behandling af insulinresistens
AU2003213719A8 (en) Multiple-component solid phases containing at least one active pharmaceutical ingredient
AP2004003055A0 (en) Platinum derivative pharmaceutical formulations.
BRPI0013439B1 (pt) composiÇço compreendendo tramadol e um fÁrmaco anticonvulsivante.
DZ3170A1 (fr) Livraison de produits pharmaceutiques instables.
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
ITTO20010005A1 (it) Formulazione farmaceutica.
EE200200201A (et) Trüosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning raviotstarbeline kasutamine.
HUP0201278A3 (en) Pyrazolecarboamide derivative, its preparation, pharmaceutical compositions containing it and its intermediates
MXPA03006884A (es) Formulacion farmaceutica.
NO20013442L (no) Sammensetninger som oppnar en forbedret levering av aktive stoffer
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
MXPA03007641A (es) Formulacion farmaceutica.
EE200200522A (et) Toimeainega konjugeerunud ensüüm-lõhustuv peptiid, seda sisaldav farmatseutiline kompositsioon ningühendi kasutamine kasvajavastase ravimina
AP2003002907A0 (en) Liquid pharmaceutical composition.
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
IL185926A (en) Annals of 2 - (3,1-Dihydro-H2-Benzimidazole-2-Illiden) -1-Alkylamidinosulfonylphenyl-3 - (Phenyl or Thienyl) -Propane-3,1
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
NO20064808L (no) Orale matrixformuleringer med licarbazepin
FR2871700B1 (fr) Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20130731